BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29725255)

  • 1. AMACR overexpression acts as a negative prognostic factor in oral squamous cell carcinoma.
    He HL; Lee YE; Chang MT; Shiue YL; Chang SL; Chen TJ; Chiu CT
    Int J Med Sci; 2018; 15(6):638-644. PubMed ID: 29725255
    [No Abstract]   [Full Text] [Related]  

  • 2. AMACR overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma.
    Lee YE; He HL; Lee SW; Chen TJ; Chang KY; Hsing CH; Li CF
    Tumour Biol; 2014 Aug; 35(8):7983-91. PubMed ID: 24833092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator.
    Wu LC; Chen LT; Tsai YJ; Lin CM; Lin CY; Tian YF; Sheu MJ; Uen YH; Shiue YL; Wang YH; Yang SJ; Wu WR; Li SH; Iwamuro M; Kobayasshi N; Huang HY; Li CF
    J Clin Pathol; 2012 Apr; 65(4):309-14. PubMed ID: 22267983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.
    Eichelberg C; Minner S; Isbarn H; Burandt E; Terracciano L; Moch H; Kell A; Heuer R; Chun FK; Sauter G; Fisch M; Tennstedt P
    World J Urol; 2013 Aug; 31(4):847-53. PubMed ID: 22009118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.
    Box A; Alshalalfa M; Hegazy SA; Donnelly B; Bismar TA
    Tumour Biol; 2016 Sep; 37(9):12287-12299. PubMed ID: 27271990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis.
    Shilo K; Dracheva T; Mani H; Fukuoka J; Sesterhenn IA; Chu WS; Shih JH; Jen J; Travis WD; Franks TJ
    Arch Pathol Lab Med; 2007 Oct; 131(10):1555-60. PubMed ID: 17922592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the expression of alpha-methylacyl-CoA racemase in squamous cell carcinoma and adenocarcinoma of the lung.
    Erdogan Y; Demirag F; Duyar SS; Yilmaz A; Yazici U; Aydoğdu K
    Acta Chir Belg; 2013; 113(4):263-9. PubMed ID: 24224435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
    BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
    Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
    Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC.
    Xu B; Cai Z; Zeng Y; Chen L; Du X; Huang A; Liu X; Liu J
    J Clin Pathol; 2014 Nov; 67(11):974-9. PubMed ID: 25092674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-methylacyl-CoA racemase/P504S overexpression in colorectal carcinoma is correlated with tumor differentiation.
    Shi X; Gong E; Wu X
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):175-80. PubMed ID: 17525630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMACR amplification in myxofibrosarcomas: a mechanism of overexpression that promotes cell proliferation with therapeutic relevance.
    Li CF; Fang FM; Lan J; Wang JW; Kung HJ; Chen LT; Chen TJ; Li SH; Wang YH; Tai HC; Yu SC; Huang HY
    Clin Cancer Res; 2014 Dec; 20(23):6141-52. PubMed ID: 25384383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of cysteine-glutamate transporter and CD44 for prediction of recurrence and survival in patients with oral cavity squamous cell carcinoma.
    Lee JR; Roh JL; Lee SM; Park Y; Cho KJ; Choi SH; Nam SY; Kim SY
    Head Neck; 2018 Nov; 40(11):2340-2346. PubMed ID: 30303590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Methylacyl-CoA racemase (AMACR) in gastric cancer: correlation with clinicopathologic data and disease-free survival.
    Mroz A; Kiedrowski M; Lewandowski Z
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):313-7. PubMed ID: 23235347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma.
    Ko HH; Cheng SL; Lee JJ; Chen HM; Kuo MY; Cheng SJ
    Head Neck; 2017 Jul; 39(7):1327-1332. PubMed ID: 28301069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
    Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
    Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach.
    Lee WA
    Oncology; 2006; 71(3-4):246-50. PubMed ID: 17652945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer.
    Barros FBA; Assao A; Garcia NG; Nonogaki S; Carvalho AL; Soares FA; Kowalski LP; Oliveira DT
    BMC Cancer; 2018 Jan; 18(1):53. PubMed ID: 29310601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression.
    Langner C; Rupar G; Leibl S; Hutterer G; Chromecki T; Hoefler G; Rehak P; Zigeuner R
    Virchows Arch; 2006 Mar; 448(3):325-30. PubMed ID: 16315020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDKN3 expression is an independent prognostic factor and associated with advanced tumor stage in nasopharyngeal carcinoma.
    Chang SL; Chen TJ; Lee YE; Lee SW; Lin LC; He HL
    Int J Med Sci; 2018; 15(10):992-998. PubMed ID: 30013440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.